NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. Founded by Mike Trower in 2012, NeRRe Therapeutics is backed by GlaxoSmithKline, OrbiMed, Novo Holdings, The Future Fund, and Advent Life Sciences and is headquartered in Stevenage.
FOUNDED:
2012
INDUSTRY:
Biotechnology, Health Care, Medical
FOUNDERS:
Mike Trower
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
